AGE Reader

Non-invasive cardiovascular risk assessment

Patient friendly diagnosis, Personalized care & Preventing disease

Wish to receive a quotation on product purchasing or leasing? Quotation request

AGE Reader in clinical care

The information of the AGE Reader can assist physicians in focusing treatment on patients with the highest risk of complications. This includes patients suffering from diabetes mellitus, renal failure but also acute disorders like acute coronary syndromes and sepsis.

The non-invasive AGE Reader measurement is in particular of added value to the classic risk factors in predicting the cardiovascular risk of diabetes patients. The AGE Reader measurement reflects the glycometabolic memory which is not covered by the classic risk markers and has been shown to add clinically relevant information to the cardiovascular risk prediction for diabetes patients.

In diabetes patients the AGE Reader has been shown to:

  • Reflect the vascular damage of a patient.
  • Identify diabetes patients at risk of developing cardiovascular complications.
  • Identify diabetes patients at risk of developing microvascular complications.
  • Be a cost-effective assessment tool that adds clinical value to conventional risk engines.

The information of the AGE Reader measurement can be especially interesting for the following applications:

  • Measurement results serves as a motivation tool for patients.
  • Assist in clinical decision making about intensifying or changing treatment of diabetes patients, such as switching to more intensive diabetes treatments or multiple therapy.
  • Assist in clinical decision making about the cut-off levels for classic cardiovascular risk markers.
  • Identify patients with an increased risk of developing complications which were not identified based on the classic cardiovascular risk markers.

The AGE Reader is already being sold internationally since 2006. You can find experiences of our customers on using the AGE Reader in diabetes care here.

Read more about the AGE Reader applications

Interested in receiving a white paper and product brochure? Please leave your name and email here.

More Information
Request informations

Would you like to learn more about our products? Request any information you wish to receive here.

The AGE Reader App!
The new AGE Reader App allows you to generate a comprehensive Cardiovascular Risk Report based on the AGE Reader measurement. For each patient all visits can be documented and consulted in the easy to use App.
Read more »
About the company

Find information about Diagnoptics.

Information for patients

Find information about Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.a